Aditya Kohli, Ph.D.

Venture Partner

Aditya is a Venture Partner on the Frazier Life Sciences team and focuses on company creation.

Aditya is a Venture Partner with Frazier Healthcare Partners, where he focuses on company creation. Since joining Frazier in 2016, he has co-founded HilleVax, Phathom Pharmaceuticals (NASDAQ: PHAT) and Scout Bio, and helped launch Passage Bio (NASDAQ: PASG). Currently, Aditya serves as the Chief Operating Officer of HilleVax, Chief Business Officer of Phathom Pharmaceuticals and as a board member of Scout Bio.

Prior to Frazier, Aditya was an Engagement Manager with McKinsey & Company, where he served biopharmaceutical companies on business development, research and development, and marketing and sales strategy.

Aditya received his Ph.D. from the UC Berkeley and UC San Francisco joint graduate program in bioengineering and holds B.S. and M.Eng. degrees in biological engineering from MIT.

Menlo Park

UC Berkeley-UCSF (Ph.D.)
Massachusetts Institute of Technology (B.S. and M.Eng.)

Year Joined